Grants per year
Search results
-
Active
Prot #OCE-205-201: A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Adaptive Dose-Ranging Study to Assess Safety and Efficacy of Intravenous OCE-205 in Adults Diagnosed with Cirrhosis with Ascites who have Developed Hepatorenal Syndrome-Acute
CTI Clinical Trial and Consulting Services, Ocelot Bio, Inc.
5/20/22 → 5/20/25
Project: Research project
-
Prot #GSN000350: TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevated Liver Stiffness
Pharmaceutical Research Associates, Inc., GenKyoTex Suisse SA
2/14/22 → 2/14/25
Project: Research project
-
Prot#GS-US-428-4194: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis
Ganger, D. R. & Flamm, S. L.
Pharmaceutical Research Associates, Inc., Gilead Sciences, Inc.
6/5/19 → 6/5/24
Project: Research project
-
A Multi-Center Group to Study Acute Liver Failure
University of Texas Southwestern Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases
9/16/15 → 8/31/23
Project: Research project